Disperazol Pharma ApS
PrivateLast Round
Grant
Jun 5, 2023
Total Funding Raised
$10,800
Company Overview
Disperazol Pharma ApS operates in Healthcare & Life Sciences and is based in Humlebæk. Its latest recorded funding round was a Grant round in June 2023.
Disperazol Pharma ApS is a biotechnology company that develops non-traditional antimicrobial compounds designed to dismantle biofilms of Gram-negative pathogens to enhance the efficacy of existing antibiotics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Disperazol Pharma ApS Comparables
Compare Disperazol Pharma ApS with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioTryp Therapeutics | 85% | |
| Resistia | 82% | |
| HHV Biotech | 80% |
For institutional investors. Book with your work email.
Disperazol Pharma ApS Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Disperazol Pharma ApS Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| INCATE | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 20, 2026
Monthly visitors grew 416% MoM, from 251 to 1.3K.
- Jun 5, 2023
$11K grant received from INCATE.
For institutional investors. Book with your work email.
Disperazol Pharma ApS Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Disperazol Pharma ApS's valuation, stock price, and market status.
Is Disperazol Pharma ApS a public or private company?
Disperazol Pharma ApS is a private company.
What is the current stock price of Disperazol Pharma ApS?
Disperazol Pharma ApS is a private company, so its shares have no public market price. Caplight tracks Disperazol Pharma ApS's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Disperazol Pharma ApS worth (valuation)?
Valuation information for Disperazol Pharma ApS is not publicly available.
Can I buy Disperazol Pharma ApS stock?
Disperazol Pharma ApS shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Disperazol Pharma ApS's last funding round?
Disperazol Pharma ApS's most recent funding round was Grant on June 5, 2023.
Who are the main investors in Disperazol Pharma ApS?
Key investors in Disperazol Pharma ApS include INCATE.
Will Disperazol Pharma ApS IPO soon?
No public IPO plans have been announced for Disperazol Pharma ApS.
How can I track Disperazol Pharma ApS secondary market activity?
Caplight tracks bids, offers, and trades in Disperazol Pharma ApS's shares on secondary markets.